Abstract
Background There is considerable variability in emotional and behavioural outcomes of children whose mothers experience depression. Few longitudinal studies have examined potential contributions of dimensions of paternal involvement in the association between maternal postnatal depression (PND) and offspring development.
Methods We examined pathways from maternal PND at 8 weeks postnatally (assessed using the Edinburgh Postnatal Depression Scale) to offspring emotional and behavioural development at 7 years (assessed using the Strengths and Difficulties Questionnaire) through behavioural, affective and cognitive child-focused and mother-influenced dimensions of paternal involvement in 3,434 members of the UK-based birth cohort, the Avon Longitudinal Study of Parents and Children. Analyses were adjusted for a range of baseline confounders and paternal postnatal depression (PND) as an intermediate confounder.
Results Maternal PND was associated with higher levels of some aspects of child-focused and mother-influenced paternal involvement in models accounting for paternal PND, however these pathways were not associated with offspring emotional and behavioural development at age 7 years. There was strong evidence of direct effect from maternal PND to offspring development, but no evidence of mediation through the combination of all indirect pathways through child-focused and mother-influenced paternal involvement. However, higher levels of father-child conflict were associated with increased risk of offspring emotional and behavioural difficulties, and this pathway mediated a proportion of the maternal PND to offspring risk. Additionally, maternal PND was associated with paternal PND, which, in turn, was associated with lower levels of child-focused and mother-influenced paternal involvement.
Conclusions The positive associations between maternal PND and some aspects of paternal involvement suggest that non-depressed fathers may engage in ‘compensatory’ parenting strategies in response to maternal PND, which although important may not be sufficient in reducing the adverse impact of maternal PND on offspring emotional and behavioural development. Conflictual father-child relationships emerged as a risk factor for adverse offspring development and as an explanatory mechanism in the association between maternal PND and offspring development. These results suggest that interventions that reduce father-child conflict may reduce the risk of emotional and behavioural difficulties in offspring of depressed mothers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and Dr Culpin will serve as guarantor for the contents of this paper. This research was funded in whole by the Wellcome Trust Research Fellowship in Humanities and Social Science (Grant ref: 212664/Z/18/Z) awarded to Dr Culpin. A comprehensive list of grants funding is available on the ALSPAC website (http://www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf). Dr Hammerton is supported by the Sir Henry Wellcome Postdoctoral Fellowship (209138/Z/17/Z). Dr Bornstein was funded by the Intramural Research Program of the NIH/NICHD, USA, and an International Research Fellowship at the Institute for Fiscal Studies, London, UK, funded by the European Research Council under the Horizon 2020 research and innovation programme (grant agreement No: 695300-HKADeC-ERC-2015-AdG). Professor Stein was supported by the NIHR Oxford Health Biomedical Research Centre. Dr Cadman received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement N: 733206, LIFE-CYCLE project. Dr Sallis is a member of the MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/7), which is supported by the UK Medical Research Council Unit (MC_UU_12013/3 and MC_UU_12013/4). Dr Pearson was supported by the European Research Commission Grant (Grant ref: 758813 MHINT). This study was also supported by the NIHR Biomedical Research Centre at the University Hospitals Bristol NHS Foundation Trust and the University of Bristol. This publication is the work of the authors who will serve as guarantors for the contents of this paper. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
ALSPAC data are available through a system of managed open access. The study website contains details of all the data that is available through a fully searchable data dictionary and variable search tool data dictionary. The application steps for ALSPAC data access are highlighted below. 1. Please read the ALSPAC access policy, which describes the process of accessing the data in detail, and outlines the costs associated with doing so. 2. You may also find it useful to browse the fully searchable research proposals database, which lists all research projects that have been approved since April 2011. 3. Please submit your research proposal for consideration by the ALSPAC Executive Committee. You will receive a response within 10 working days to advise you whether your proposal has been approved.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
If you have any questions about accessing data, please email alspac-data@bristol.ac.uk.